Based on notional value, the top 3 ETF holders of Crispr Therapeutics (CRSP) are ARKK ($292.2M), ARKG ($76.9M) and XBI ($67.3M).
| FUND | HOLDING | % OF FUND | VALUE ($) |
|---|---|---|---|
ARKK | Crispr Therapeutics (CRSP) | 5.511% | $292.2M |
ARKG | Crispr Therapeutics (CRSP) | 8.002% | $76.9M |
XBI | Crispr Therapeutics (CRSP) | 1.381% | $67.3M |
IBB | Crispr Therapeutics (CRSP) | 0.373% | $19.8M |
XT | Crispr Therapeutics (CRSP) | 0.476% | $14.4M |
VXF | Crispr Therapeutics (CRSP) | 0.04% | $7.9M |
VHT | Crispr Therapeutics (CRSP) | 0.05% | $7.7M |
LABU | Crispr Therapeutics (CRSP) | 0.837% | $4.8M |
ITOT | Crispr Therapeutics (CRSP) | 0.006% | $3.8M |
GNOM | Crispr Therapeutics (CRSP) | 4.459% | $2.2M |
Investment Managers Series Trust II - AXS Sustainable Alpha ETF | Crispr Therapeutics (CRSP) | 3.136% | $1.3M |
ESGV | Crispr Therapeutics (CRSP) | 0.01% | $941,673.60 |
ESML | Crispr Therapeutics (CRSP) | 0.053% | $898,228.05 |
Main Thematic Innovation ETF | Crispr Therapeutics (CRSP) | 0.574% | $773,203.86 |
iShares Morningstar Small-Cap Value ETF | Crispr Therapeutics (CRSP) | 0.103% | $430,389.86 |
iShares Morningstar Small-Cap Value ETF | Crispr Therapeutics (CRSP) | 0.101% | $422,032.78 |
Horizon Kinetics Medical ETF | Crispr Therapeutics (CRSP) | 2.662% | $417,141.55 |
IDNA | Crispr Therapeutics (CRSP) | 0.336% | $365,239.89 |
BBP | Crispr Therapeutics (CRSP) | 1.55% | $353,385.79 |
SMLF | Crispr Therapeutics (CRSP) | 0.02% | $314,764.63 |
JKK | Crispr Therapeutics (CRSP) | 0.05% | $300,072.15 |
iShares Morningstar Small-Cap Growth ETF | Crispr Therapeutics (CRSP) | 0.05% | $300,072.15 |
JKJ | Crispr Therapeutics (CRSP) | 0.077% | $164,593.64 |
iShares Morningstar Small-Cap ETF | Crispr Therapeutics (CRSP) | 0.077% | $164,593.64 |
IYY | Crispr Therapeutics (CRSP) | 0.007% | $152,077.67 |
Holdings are tracked for approximately 2000 ETFs.
